Overview
Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
Status:
Completed
Completed
Trial end date:
2005-09-01
2005-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This trial is conducted in Asia, Europe, and Middle East. Adult patients with chronic kidney disease are treated with growth hormone to assess effect on nutritional status.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Novo Nordisk A/S
Criteria
Inclusion Criteria:- ESRD patients
Exclusion Criteria:
- Diabetes Mellitus
- Severe and Malignant diseases
- Patients in Intensive Care Units